tiprankstipranks
Trending News
More News >
Diaceutics (GB:DXRX)
LSE:DXRX
UK Market

Diaceutics (DXRX) Ratios

Compare
10 Followers

Diaceutics Ratios

GB:DXRX's free cash flow for Q2 2024 was £0.70. For the 2024 fiscal year, GB:DXRX's free cash flow was decreased by £ and operating cash flow was £-0.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
4.85 8.23 11.41 11.53 8.23
Quick Ratio
4.85 8.23 11.41 11.53 8.23
Cash Ratio
2.98 5.29 7.47 8.66 5.23
Solvency Ratio
0.22 0.65 0.54 0.33 0.30
Operating Cash Flow Ratio
0.38 1.37 0.22 0.09 -0.28
Short-Term Operating Cash Flow Coverage
14.09 0.00 4.38 2.14 -5.83
Net Current Asset Value
£ 20.54M£ 25.15M£ 25.70M£ 30.34M£ 16.18M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.03 0.03 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 0.03 0.04 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 0.03 0.04 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.17 1.14 1.11 1.08 1.11
Debt Service Coverage Ratio
3.55 31.59 10.92 8.62 2.74
Interest Coverage Ratio
-85.48 2.71 3.56 -14.88 9.54
Debt to Market Cap
<0.01 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
<0.01 0.02 0.02 <0.01 <0.01
Net Debt to EBITDA
-64.09 -5.13 -8.58 -141.22 -13.70
Profitability Margins
Gross Profit Margin
75.18%71.97%75.78%73.50%76.70%
EBIT Margin
-14.32%3.51%3.94%-4.97%4.19%
EBITDA Margin
0.99%18.50%15.15%1.40%6.31%
Operating Profit Margin
-17.03%1.70%2.24%-4.80%15.78%
Pretax Profit Margin
-14.36%2.45%2.10%-7.32%2.53%
Net Profit Margin
-10.90%3.71%4.02%2.07%2.96%
Continuous Operations Profit Margin
-10.90%3.71%4.02%2.07%2.96%
Net Income Per EBT
75.93%151.46%191.47%-28.31%116.95%
EBT Per EBIT
84.30%144.41%93.61%152.30%16.05%
Return on Assets (ROA)
-6.26%1.50%1.25%0.60%1.78%
Return on Equity (ROE)
-7.15%1.70%1.38%0.65%1.98%
Return on Capital Employed (ROCE)
-11.16%0.74%0.74%-1.50%10.53%
Return on Invested Capital (ROIC)
-9.76%1.12%1.40%0.42%12.25%
Return on Tangible Assets
-9.21%2.19%1.74%0.77%2.14%
Earnings Yield
-2.64%1.14%0.66%0.25%0.61%
Efficiency Ratios
Receivables Turnover
2.69 1.87 0.00 0.00 0.00
Payables Turnover
10.62 7.20 6.58 7.22 30.18
Inventory Turnover
0.00 5.47M 0.00 0.00 3.13M
Fixed Asset Turnover
14.47 9.32 6.55 53.34 100.61
Asset Turnover
0.57 0.40 0.31 0.29 0.60
Working Capital Turnover Ratio
1.15 0.71 0.48 0.54 1.44
Cash Conversion Cycle
101.07 144.46 -55.45 -50.56 -12.09
Days of Sales Outstanding
135.45 195.13 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 <0.01 0.00 0.00 <0.01
Days of Payables Outstanding
34.38 50.67 55.45 50.56 12.09
Operating Cycle
135.45 195.13 0.00 0.00 <0.01
Cash Flow Ratios
Operating Cash Flow Per Share
0.03 0.06 <0.01 <0.01 >-0.01
Free Cash Flow Per Share
0.02 <0.01 -0.06 -0.08 -0.06
CapEx Per Share
<0.01 0.06 0.07 0.08 0.05
Free Cash Flow to Operating Cash Flow
0.94 0.05 -8.83 -23.88 5.67
Dividend Paid and CapEx Coverage Ratio
16.91 1.06 0.10 0.04 -0.21
Capital Expenditure Coverage Ratio
16.91 1.06 0.10 0.04 -0.21
Operating Cash Flow Coverage Ratio
14.09 3.87 0.37 2.14 -5.83
Operating Cash Flow to Sales Ratio
0.08 0.26 0.04 0.02 -0.05
Free Cash Flow Yield
1.85%0.44%-5.88%-5.84%-5.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-37.85 87.75 152.61 393.56 164.20
Price-to-Sales (P/S) Ratio
4.13 3.26 6.14 8.15 4.86
Price-to-Book (P/B) Ratio
2.78 1.49 2.11 2.57 3.25
Price-to-Free Cash Flow (P/FCF) Ratio
54.15 228.54 -17.02 -17.13 -18.39
Price-to-Operating Cash Flow Ratio
50.93 12.34 150.20 409.12 -104.22
Price-to-Earnings Growth (PEG) Ratio
0.60 3.09 1.57 -8.71 -5.15
Price-to-Fair Value
2.78 1.49 2.11 2.57 3.25
Enterprise Value Multiple
351.72 12.48 31.96 440.28 63.40
Enterprise Value
EV to EBITDA
351.72 12.48 31.96 440.28 63.40
EV to Sales
3.49 2.31 4.84 6.17 4.00
EV to Free Cash Flow
45.80 161.95 -13.42 -12.97 -15.12
EV to Operating Cash Flow
43.09 8.75 118.42 309.76 -85.70
Tangible Book Value Per Share
0.29 0.32 0.33 0.40 0.26
Shareholders’ Equity Per Share
0.46 0.51 0.48 0.52 0.31
Tax and Other Ratios
Effective Tax Rate
0.12 -0.51 -0.91 1.28 -0.17
Revenue Per Share
0.31 0.23 0.17 0.16 0.21
Net Income Per Share
-0.03 <0.01 <0.01 <0.01 <0.01
Tax Burden
0.76 1.51 1.91 -0.28 1.17
Interest Burden
1.00 0.70 0.53 1.47 0.60
Research & Development to Revenue
0.00 0.00 0.00 0.00 <0.01
SG&A to Revenue
0.46 0.83 0.85 0.79 0.62
Stock-Based Compensation to Revenue
0.01 0.03 0.03 0.02 <0.01
Income Quality
-0.74 7.11 1.02 0.96 -1.58
Currency in GBP
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis